Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating HRS-1301 tablets in healthy subjects and in individuals with impaired kidney function to assess safety and pharmacokinetics in hyperlip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-1301

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Hyperlipidemias | Phase 1 | Status: NOT_YET_RECRUITING